DE VITIS, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 2.374
EU - Europa 1.599
AS - Asia 232
AF - Africa 24
OC - Oceania 15
SA - Sud America 11
Totale 4.255
Nazione #
US - Stati Uniti d'America 2.273
IE - Irlanda 742
IT - Italia 487
CA - Canada 101
IN - India 96
SE - Svezia 76
DE - Germania 65
CN - Cina 64
SG - Singapore 57
FI - Finlandia 52
GB - Regno Unito 44
UA - Ucraina 33
TG - Togo 23
BG - Bulgaria 20
BE - Belgio 15
ES - Italia 15
AU - Australia 11
FR - Francia 10
AR - Argentina 9
NL - Olanda 8
RU - Federazione Russa 8
HK - Hong Kong 5
CH - Svizzera 4
NZ - Nuova Zelanda 4
RO - Romania 4
CZ - Repubblica Ceca 3
AT - Austria 2
GR - Grecia 2
JP - Giappone 2
KH - Cambogia 2
KR - Corea 2
PL - Polonia 2
BN - Brunei Darussalam 1
BR - Brasile 1
CO - Colombia 1
EE - Estonia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 4.255
Città #
Dublin 741
Fairfield 311
Rome 219
Ashburn 200
Chandler 197
Seattle 138
Woodbridge 113
Houston 112
Wilmington 101
Cambridge 92
New York 52
Ann Arbor 44
Princeton 43
Dearborn 38
San Paolo di Civitate 37
Toronto 33
Plano 30
Lawrence 29
Helsinki 28
Singapore 26
Lomé 23
San Diego 21
Millbury 20
Boston 19
Fremont 19
Sofia 19
Boardman 17
Los Angeles 16
Beijing 15
Des Moines 14
Milan 14
Brussels 13
Omaha 13
Phoenix 13
Berlin 11
Bremen 11
Shanghai 11
Washington 11
Nashville 10
Andover 9
Fayetteville 9
Jacksonville 9
San Francisco 9
Calgary 8
Chicago 8
London 8
Norwalk 8
Austin 7
Cagliari 7
Denver 7
Federal 7
Gainesville 7
Pacific Palisades 7
Ottawa 6
Philadelphia 6
Pittsburgh 6
Portland 6
Dallas 5
Düsseldorf 5
Laurel 5
Mataró 5
Pune 5
Sacramento 5
Adelaide 4
Albuquerque 4
Bolzano 4
Brooklyn 4
Camarillo 4
Christchurch 4
Erie 4
Formello 4
Kitchener 4
Kunming 4
Mississauga 4
Montreal 4
Nanjing 4
Nuremberg 4
Regina 4
Salerno 4
San Jose 4
San Mateo 4
Santa Clarita 4
Tower Hamlets 4
Wasilla 4
Bellaria-Igea Marina 3
Bristol 3
Brno 3
Buffalo 3
Bühl 3
Charlotte 3
Clovis 3
Columbus 3
Decatur 3
Hanover 3
Hong Kong 3
Islington 3
Leland 3
McKinney 3
Melbourne 3
Minneapolis 3
Totale 3.170
Nome #
AIDS and COVID-19 are two diseases separated by a common lymphocytopenia 677
Studio della regolazione trascrizionale della Stearoyl-CoA Desaturase 1 (SCD1) in Cellule Staminali Tumorali di adenocarcinoma del polmone 122
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells 119
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma 116
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions 115
B4GALT1 is a new candidate to maintain the stemness of lung cancer stem cells 113
Lung cancer stem cell lose their stemness default state after exposure to microgravity. 105
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ 105
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 104
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity 104
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children 101
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 100
“HER3 as an emerging target for lung tumor initiating cells”. 96
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma 95
Assessing static lung hyperinflation by whole-body plethysmography, helium dilution, and impulse oscillometry system (IOS) in patients with COPD 91
Metabolic features of cancer stem cells. the emerging role of lipid metabolism 90
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies 88
Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors 85
”Isolated cancer initiating cells of metastatic lung adenocarcinoma from pleural effusion are tumorigenic in NOD-SCID mice 85
Neurotrophin system activation in pleural effusions 82
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung 81
Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes 81
WT1 CpG islands methylation in human lung cancer: A pilot study 80
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer 79
Spheres derived from lung adenocarcinoma pleural effusions: Molecular characterization and tumor engraftment 79
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium 76
EMT markers in lung adenocarcinoma pleural effusion spheroid cells 75
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients 74
H-Ras gene takes part to the host immune response to COVID-19 71
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells 70
Nonthyroidal illness syndrome. to treat or not to treat? Have we answered the question? A review of metanalyses 65
Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients 64
mRNAs: profilo di espressione nella patologia preneoplastica della cervice uterina e loro possibile ruolo nella carcinogenesi. Dati Preliminari. 63
MicroRNA-551b expression profile in low and high-grade cervical intraepithelial neoplasia 62
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies 62
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients 62
Age is not the only risk factor in {COVID}-19: the role of comorbidities and of long staying in residential care homes.{&}nbsp$mathsemicolon$ 62
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients 60
SCD1, autophagy and cancer: implications for therapy 59
Bioelectrical Impedance Analysis (BIA) to measure alterations on hydroelectrolytic equilibrium of peripheral cells in COVID-19 patients with nonthyroidal illness syndrome (NTIS) 52
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 51
Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients 47
MiRNAs: profilo di espressione nella patologia preneoplastica della cervice uterina e loro possibile ruolo nella carcinogenesi. Dati preliminari 47
Molecular characterization of spheroid cultures from lung adenocarcinoma pleural effusion 45
Surfactant Protein B Plasma Levels. Reliability as a Biomarker in COPD Patients 44
Stearoyl-CoA desaturase 1 is a key factor for lung cancer stem cell survival and expansion. 44
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis 43
miRNAs as candidate biomarker for the accurate detection of atypical endometrial hyperplasia/endometrial intraepithelial neoplasia 39
Histologic analysis of idiopathic pulmonary fibrosis by morphometric and fractal analysis 28
Adenocarcinomas of the Lung and Neurotrophin System. A Review 28
Complete pseudo-anodontia in an adult woman with pseudo-hypoparathyroidism type 1a: a new additional nonclassical feature? 22
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients 6
Totale 4.414
Categoria #
all - tutte 10.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019172 0 0 0 0 0 0 0 0 0 0 97 75
2019/2020570 60 25 6 19 61 87 90 65 56 48 29 24
2020/2021284 18 23 17 30 10 21 2 20 28 71 29 15
2021/2022556 15 25 46 21 66 19 22 55 40 22 155 70
2022/20231.385 86 124 56 77 107 108 48 42 659 15 36 27
2023/20241.205 37 56 44 56 71 184 580 92 26 54 5 0
Totale 4.414